Free Trial

CareCloud's (CCLD) "Sell (D+)" Rating Reaffirmed at Weiss Ratings

CareCloud logo with Medical background

Key Points

  • CareCloud's stock has been reaffirmed with a "sell (D+)" rating by Weiss Ratings, indicating a negative outlook for investors.
  • In contrast, Wall Street Zen recently upgraded CareCloud from a "hold" rating to a "buy" rating, suggesting some analysts see potential for growth.
  • CareCloud's shares have seen a 3.6% decrease in trading, reaching $3.47, with a reported earnings miss of $0.07 per share against expectations of $0.08.
  • Five stocks we like better than CareCloud.

CareCloud (NASDAQ:CCLD - Get Free Report)'s stock had its "sell (d+)" rating reiterated by Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen upgraded shares of CareCloud from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, CareCloud currently has an average rating of "Hold" and a consensus price target of $2.50.

Check Out Our Latest Analysis on CCLD

CareCloud Trading Down 3.6%

Shares of CCLD traded down $0.13 during trading hours on Wednesday, reaching $3.47. 446,124 shares of the stock traded hands, compared to its average volume of 608,042. CareCloud has a 52-week low of $1.14 and a 52-week high of $4.84. The company's 50-day moving average price is $3.17 and its two-hundred day moving average price is $2.39. The company has a market cap of $146.85 million, a P/E ratio of -86.75 and a beta of 2.10.

CareCloud (NASDAQ:CCLD - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.01). The firm had revenue of $27.38 million for the quarter, compared to analysts' expectations of $27.19 million. CareCloud had a net margin of 10.08% and a return on equity of 23.51%. CareCloud has set its FY 2025 guidance at 0.100-0.130 EPS. On average, research analysts forecast that CareCloud will post 0.58 EPS for the current year.

Institutional Investors Weigh In On CareCloud

Large investors have recently added to or reduced their stakes in the stock. HighTower Advisors LLC purchased a new stake in CareCloud in the 1st quarter valued at about $28,000. Vanguard Personalized Indexing Management LLC purchased a new stake in CareCloud in the 2nd quarter valued at about $50,000. XTX Topco Ltd purchased a new stake in CareCloud in the 1st quarter valued at about $35,000. Kingsview Wealth Management LLC purchased a new stake in CareCloud in the 1st quarter valued at about $36,000. Finally, Axxcess Wealth Management LLC purchased a new stake in CareCloud in the 1st quarter valued at about $41,000. 10.16% of the stock is owned by hedge funds and other institutional investors.

CareCloud Company Profile

(Get Free Report)

CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CareCloud Right Now?

Before you consider CareCloud, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareCloud wasn't on the list.

While CareCloud currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.